Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Semaglutide for Chronic Kidney Disease in Type 2 Diabetes
Recruiting1 awardPhase 3
Coral Gables, Florida
This trial is testing whether semaglutide can help slow down the progression of kidney disease in people with type 2 diabetes. Participants will be given either semaglutide or a placebo, and neither they nor the researchers will know who is receiving which. The study will last for 3-5 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.